LIGAND PHARMACEUTICALS INC's ticker is LGND and the CUSIP is 53220K504. A total of 199 filers reported holding LIGAND PHARMACEUTICALS INC in Q2 2022. The put-call ratio across all filers is 0.22 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $852,781 | +37.5% | 14,232 | +158.2% | 0.00% | 0.0% |
| Q1 2022 | $620,000 | -67.1% | 5,512 | -54.8% | 0.00% | -66.7% |
| Q4 2021 | $1,884,000 | +193.9% | 12,200 | +165.2% | 0.01% | +100.0% |
| Q3 2021 | $641,000 | -35.3% | 4,600 | -29.2% | 0.00% | -25.0% |
| Q1 2021 | $990,000 | +145.7% | 6,500 | +80.6% | 0.00% | +100.0% |
| Q2 2020 | $403,000 | -77.3% | 3,600 | -78.8% | 0.00% | -84.6% |
| Q4 2019 | $1,772,000 | +78.1% | 17,000 | +70.0% | 0.01% | +62.5% |
| Q3 2019 | $995,000 | -65.4% | 10,000 | -60.3% | 0.01% | -68.0% |
| Q2 2019 | $2,877,000 | +1244.4% | 25,200 | +1382.4% | 0.02% | +1150.0% |
| Q1 2019 | $214,000 | -14.4% | 1,700 | -7.8% | 0.00% | +100.0% |
| Q4 2018 | $250,000 | -92.6% | 1,844 | -85.0% | 0.00% | -94.4% |
| Q3 2018 | $3,376,000 | +41.7% | 12,300 | +7.0% | 0.02% | +38.5% |
| Q2 2018 | $2,383,000 | +11815.0% | 11,500 | +5650.0% | 0.01% | – |
| Q2 2015 | $20,000 | – | 200 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| BVF INC/IL | 2,626,160 | $138,136,000 | 24.17% |
| KNOTT DAVID M | 1,292,566 | $67,988,972,000 | 13.87% |
| GROW Partners, LLC | 200,000 | $10,520,000 | 6.41% |
| Opaleye Management Inc. | 90,000 | $4,860,000,000 | 3.82% |
| OBERWEIS ASSET MANAGEMENT INC/ | 213,317 | $11,220,000 | 2.72% |
| First Light Asset Management, LLC | 60,242 | $3,169,000 | 2.69% |
| Timpani Capital Management LLC | 98,956 | $5,205,000 | 2.59% |
| Iguana Healthcare Management, LLC | 75,000 | $3,945,000 | 2.25% |
| Eventide Asset Management | 134,400 | $7,069,000 | 2.18% |
| ASHFORD CAPITAL MANAGEMENT INC | 215,223 | $11,321,000 | 2.16% |